The Story Of Our Firm | En Español
 Home    Lawyers   Litigation   Choose Us   Settlements   Search

Drugs ReNu MoistureLoc Research Center

FDA Supports Withdrawal

in this section: FDA ReNu Recall | W & L Press Release | FDA: Failure to Report, 11.06 | B&L Responds: ReNu FDA Letter 11.06 | FDA Warning | Litigation Proliferates, 10.07 | FDA Supports Withdrawal | FDA Public Health Notice | B&L Sales Fall | Bausch & Lomb Press Release | MultiPlus Recall, 3/07 | ReNu lawsuit

Bookmark This Page Print This Page Email This Page

FDA Supports Bausch & Lomb’s Voluntary Market Withdrawal of ReNu MoistureLoc Contact Lens Solution

The following is the announcement by the FDA on April 14, 2006 stating that they support the withdrawal of ReNu MoistureLoc contact lens solution from the marketplace in the United States.

The experienced dangerous drug attorneys at Weitz & Luxenberg can help you fight back against the manufacturer of the ReNu contact lens solution by filing a lawsuit if you developed a fungal eye infection and are suffering from loss of vision. For a free case evaluation, fill out this simple form and we will review your case within 24 hours.


FDA Statement

FOR IMMEDIATE RELEASE
Statement
April 14, 2006

Media Inquiries:
Press Office, 301-827-6242
Consumer Inquiries:
888-INFO-FDA


FDA Statement Regarding Voluntary Market Withdrawal of Bausch & Lomb ReNu MoistureLoc® Contact Lens Solution

FDA is continuing to work closely with the Centers for Disease Control and Prevention (CDC) and Bausch & Lomb to investigate the source of Fusarium keratitis eye infections. The agency supports Bausch & Lomb's decision to voluntarily withdraw ReNu MoistureLoc® contact lens solution from the market until the agencies have had a chance to conclude their investigation.

FDA started its investigation of the Bausch & Lomb manufacturing plant on March 22, 2006, and will continue inspections of the Greenville, SC manufacturing plant and other facilities through next week. While the investigation continues, FDA will work with CDC to identify and confirm cases of Fusarium keratitis reported by state health departments and from FDA Medwatch reports.

FDA and CDC are advising consumers to take precautions to reduce their risk for Fusarium keratitis through preventive practices for contact lens wearers that include:

  • Wash hands with soap and water, and dry (lint-free method) before handling lenses.
  • Wear and replace lenses according to the schedule prescribed by the doctor.
  • Follow the specific lens cleaning and storage guidelines from the doctor and the solution manufacturer.
  • Keep the contact lens case clean and replace every 3-6 months.
  • Remove the lenses and consult your doctor immediately if you experience symptoms such as redness, pain, tearing, increased light sensitivity, blurry vision, discharge or swelling.

For more information, please visit FDA’s Contact Lens and Eye Infections page at: http://www.fda.gov/oc/opacom/hottopics/contacts.html

####

Click To Talk To Us Online

Please complete the following questionnaire:

How long have you worn contact lenses?
How long have you been using ReNu with MoistureLoc contact lens solution?
Have you developed: fungal eye infection
any loss of vision
Were you using ReNu with MoistureLoc in the month prior to your eye infection?Yes
No
Have you sought treatment from a physician for your symptoms?Yes
No
Have you had a corneal transplant?Yes
No
Have you been told by a Doctor that you may need a corneal transplant?Yes
No
If yes to any of the above, please describe:
Additional Comments/Questions
Name
Email
Phone Number


see also:

B&L Sales Fall Recall of Renu With MoistureLoc Results in Falling Sales for B&L
Lower 2006 Sales Due to Worldwide Recall of Renu MoistureLoc

FDA Warning FDA warns against Bausch & Lomb's ReNu with MoistureLoc lens solution
Legal help for people with eye infections from Bausch & Lomb's ReNu

News & Warnings ReNu Lawsuit - Bausch & Lomb’s Contact Lens Solution News & Warnings
Keep up to date with ReNu Brand contact lens solution News & Warnings

Name Phone Email
Do you have a legal question? Ask us!   strictly confidential
Your Question

Click here for a free case review

Asbestos/Mesothelioma
Accidents/General Injury
Dangerous Drugs
Environmental Pollution
Medical Malpractice

$53 million verdict — brake mechanic suffering from mesothelioma

$13.5 million verdict — one of the very first Vioxx trial cases

$15 million settlement — man wound up a paraplegic due to negligent hospital care

$37 million verdict — 2 asbestos lung cancer plaintiffs

$47 million verdict — boilermaker who died from mesothelioma

$2.6 million settlement — ill-fitting prosthesis caused decubitus ulcers

$75 million verdict — historic consolidated trial involving men who had worked at the Brooklyn Navy Yard in the 1940s and 1950s

$12.7 million verdict — iron worker who was injured due to unsafe working conditions

$8 million settlement — obstetrical malpractice resulted in neurological deficits

$64.65 million award — 4 asbestos plaintiffs

$17.5 million — consolidated trial of 5 mesothelioma victims


Ask a Free Question:
Were you injured?

check for your response [login]
For legal help anywhere in the U.S.
A nationally-recognized personal injury law firm, Weitz & Luxenberg is committed to helping clients win cases, get the compensation to which they’re entitled and continue with their lives. In just over 20 years, we’ve collected more than $1.3 billion for plaintiffs.